Stocksigma LogoStocksigma Logo

Amanta Healthcare Reports Zero Deviation in IPO Proceeds Utilization for Sep'26 Quarter

Amanta Healthcare confirmed zero deviation in utilizing its ₹126 crore IPO proceeds for the quarter ended 30th Sep'26

Amanta Healthcare Reports Zero Deviation in IPO Proceeds Utilization for Sep'26 Quarter

Amanta Healthcare Ltd · Others (Uncategorized) · 03 Nov 2026, 11:07 pm

Amanta Healthcare Reports Zero Deviation in IPO Proceeds Utilization for Sep'26 Quarter Amanta Healthcare confirmed zero deviation in utilizing its ₹126 crore IPO proceeds for the quarter ended 30th Sep'26. Monitored by CRISIL Ratings, cumulative deployment reached ₹67.02 crore of the ₹70.00 crore allocated for the SteriPort manufacturing line capex and ₹7.94 crore of the ₹30.13 crore earmarked for the SVP line capex at Hariyala, Gujarat. Issue expenses were fully utilized at ₹22.85 crore (adjusted for GST), with general corporate purpose deployment at ₹3.02 crore.

Original exchange filing (PDF)

More announcements from Amanta Healthcare Ltd

All Amanta Healthcare Ltd announcements